Vascular medial hyperplasia following chronic, intermittent exposure to 4,4'-methylenedianiline.
4,4'-Methylenedianiline (DAPM) is an aromatic amine used in the synthesis of polyurethanes and epoxy resins. Acute exposure to DAPM produces hepatobiliary toxicity in humans as well as animal models. However, the toxic effects of intermittent DAPM exposure have not been explored. We treated male and female rats with 25 mg DAPM/kg or vehicle once per week for 17-22 wk. Though concentric fibrosis around bile ducts of the liver was noted, vascular medial hyperplasia was also prominent. Morphometric analysis of histologic sections revealed that in male rats, vessel wall area increased relative to lumen area in hepatic arteries by 22 wk. However, in female rats, wall areas of both hepatic and pulmonary arteries increased relative to lumen area by 17 wk. In both male and female rats, increased wall thickness was localized to the medial layer; no intimal changes were noted. In vitro treatment of vascular smooth muscle cells (VSMC) with 25-100 microM DAPM resulted in increased DNA synthesis and VSMC proliferation. To test whether the observed alterations in cell cycle control involved VSMC-mediated metabolism of DAPM to electrophilic intermediates, cells were treated with DAPM or DAPM plus 50 microM N-acetylcysteine (NAC). Coincubation with NAC afforded dramatic protection against DAPM-induced VSMC proliferation. Though DAPM had no appreciable effect on levels of reduced glutathione, oxidized glutathione, or oxidant production, DAPM increased glutathione-S-transferase activity in VSMC. These data indicate that DAPM can initiate VSMC proliferation, possibly via VSMC-mediated metabolism of DAPM to reactive intermediates.
Dugas
Tammy R
TR
Department of Pharmacology and Therapeutics, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA. tdugas@lsuhsc.edu
Kanz
Mary F
MF
Hebert
Valeria Y
VY
Hennard
Kendall L
KL
Liu
Hanlin
H
Santa Cruz
Vicente
V
Conklin
Daniel
D
Boor
Paul J
PJ
D000111:Acetylcysteine / Q000494:pharmacology; D000814:Aniline Compounds / Q000493:pharmacokinetics / Q000633:toxicity*; D000818:Animals; D001652:Bile Ducts / Q000473:pathology; D001711:Biotransformation; D001808:Blood Vessels / Q000187:drug effects* / Q000473:pathology*; D002273:Carcinogens / Q000493:pharmacokinetics / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000473:pathology; D005260:Female; D005355:Fibrosis / Q000473:pathology; D016166:Free Radical Scavengers / Q000494:pharmacology; D005982:Glutathione Transferase / Q000378:metabolism; D006499:Hepatic Artery / Q000473:pathology; D006965:Hyperplasia; D008105:Liver Cirrhosis, Biliary / Q000139:chemically induced / Q000473:pathology; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000473:pathology*; D010084:Oxidation-Reduction; D011169:Portal Vein / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012727:Sex Characteristics; D001559:Benzhydryl Compounds
D000111:Acetylcysteine; D000814:Aniline Compounds; D002273:Carcinogens; D016166:Free Radical Scavengers; D005982:Glutathione Transferase; C009505:4,4'-diaminodiphenylmethane; D001559:Benzhydryl Compounds